Serotonin-mediated striatal dopamine release involves the dopamine uptake site and the serotonin receptor

Brain Research Bulletin

Volumn 53, Issue 3, 2000, Pages 353-357

  Sershen, Henry ^a   Hashim, Audrey ^a   Lajtha, Abel ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

5HT receptors; Dopamine release; Dopamine transporter; Serotonin; Striatum

Indexed keywords

4 (4 METHYL 1 PIPERAZINYL) 7 TRIFLUOROMETHYLPYRROLO[1,2 A]QUINOXALINE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 3 PIPERIDINOPROPYL ESTER; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 6 NITROQUIPAZINE MALEATE; BICUCULLINE; COCAINE; DIZOCILPINE; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; GLUTAMATE RECEPTOR ANTAGONIST; KETANSERIN; METITEPINE; OXYMETAZOLINE; PRESYNAPTIC RECEPTOR; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 1A AGONIST; SEROTONIN 1B AGONIST; SEROTONIN 1C RECEPTOR; SEROTONIN 1D AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN 6 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; VANOXERINE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; MOUSE; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; REGULATORY MECHANISM; SEROTONIN RELEASE;

ANIMALS; BICUCULLINE; COCAINE; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GABA ANTAGONISTS; KETANSERIN; MALE; METHIOTHEPIN; MICE; MICE, INBRED C57BL; OXYMETAZOLINE; PIPERAZINES; QUINOXALINES; QUIPAZINE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0033663988     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(00)00358-0     Document Type: Article

References (37)

1. Facilitation of dopamine release in vivo by serotonin agonists: Studies with microdialysis
2. Serotonin-facilitated dopamine release in vivo: Pharmacological characterization
3. 5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis
4. Dopamine releasing effect of phenylbiguanide in rat striatal slices
5. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum
6. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: A microdialysis study in the halothane-anesthetized rat
7. Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: A comparison between the effects of 5-hydroxytryptamine, acetylcholine, and glutamate
8. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites
9. Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum
10. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935
11. Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum
12. Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: A comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine
13. 5-Hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons
14. Serotonin-dopamine interaction and its relevance to schizophrenia
15. A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum
16. MDMA induced dopamine release in vivo: Role of endogenous serotonin
17. Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation
18. Non-serotonergic [3H]ketanserin binding sites in striatal membranes are associated with a dopac release system on dopaminergic nerve endings
19. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs
20. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
21. 5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices
22. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis
23. Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices
24. Localization of serotonin-4 receptors in the striatonigral pathway in rat brain
25. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes
26. The effect of ibogaine on kappa-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6By mice
27. Effect of ibogaine on cocaine-induced efflux of [3H] dopamine and [3H] serotonin from mouse striatum
28. Ibogaine and cocaine abuse: Pharmacological interactions at dopamine and serotonin receptors
29. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis
30. Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices
31. Ability of 5-HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo
32. 5-HT4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: A microdialysis study
33. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition
34. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system
35. Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: Role of calcium-dependent release mechanisms
36. Effect of cocaine and 5-HT3 receptor antagonists on 5-HT-induced [3H]dopamine release from rat striatal synaptosomes
37. Role of 5-HT3 receptors in basal and K(+n)-evoked dopamine release from rat olfactory tubercle and striatal slices